Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Joachim Silber"'
Autor:
Joachim Silber, Anders Jacobsen, Tatsuya Ozawa, Girish Harinath, Alicia Pedraza, Chris Sander, Eric C Holland, Jason T Huse
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e33844 (2012)
Glioblastoma (GBM) and other malignant gliomas are aggressive primary neoplasms of the brain that exhibit notable refractivity to standard treatment regimens. Recent large-scale molecular profiling has revealed distinct disease subclasses within mali
Externí odkaz:
https://doaj.org/article/62412012914a4a3a8f9e99a972369f90
Autor:
Triparna Sen, Charles M. Rudin, Richard P. Koche, Brian Loomis, John T. Poirier, Natasha Rekhtman, Marina K. Baine, Elisa de Stanchina, Juan Qiu, Helena A. Yu, Travis J. Hollmann, Michael H. Roehrl, Christine A. Iacobuzio-Donahue, Joachim Silber, Sonali Sinha, Marina Asher, Irina Linkov, Umesh K. Bhanot, Jacklynn Egger, Sam E. Tischfield, Jordana Ray-Kirton, Jason C. Chang, Michael Offin, Andrew Chow, Metamia Ciampricotti, Joseph M. Chan, Helen H. Won, Mark T.A. Donoghue, Parvathy Manoj, Fathema Uddin, Fanli Meng, Shweta S. Chavan, Maysun M. Hasan, Yingqian A. Zhan, Hirokazu Taniguchi, Alvaro Quintanal-Villalonga
Lineage plasticity is implicated in treatment resistance in multiple cancers. In lung adenocarcinomas (LUAD) amenable to targeted therapy, transformation to small cell lung cancer (SCLC) is a recognized resistance mechanism. Defining molecular mechan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19866bcbfca6f0bd1b206c8dae81ff58
https://doi.org/10.1158/2159-8290.c.6549461
https://doi.org/10.1158/2159-8290.c.6549461
Autor:
Triparna Sen, Charles M. Rudin, Richard P. Koche, Brian Loomis, John T. Poirier, Natasha Rekhtman, Marina K. Baine, Elisa de Stanchina, Juan Qiu, Helena A. Yu, Travis J. Hollmann, Michael H. Roehrl, Christine A. Iacobuzio-Donahue, Joachim Silber, Sonali Sinha, Marina Asher, Irina Linkov, Umesh K. Bhanot, Jacklynn Egger, Sam E. Tischfield, Jordana Ray-Kirton, Jason C. Chang, Michael Offin, Andrew Chow, Metamia Ciampricotti, Joseph M. Chan, Helen H. Won, Mark T.A. Donoghue, Parvathy Manoj, Fathema Uddin, Fanli Meng, Shweta S. Chavan, Maysun M. Hasan, Yingqian A. Zhan, Hirokazu Taniguchi, Alvaro Quintanal-Villalonga
Supplemental figures and figure legends.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15cdf6100787567edd1d3c55a0d31bc8
https://doi.org/10.1158/2159-8290.22540724
https://doi.org/10.1158/2159-8290.22540724
Autor:
Triparna Sen, Charles M. Rudin, Richard P. Koche, Brian Loomis, John T. Poirier, Natasha Rekhtman, Marina K. Baine, Elisa de Stanchina, Juan Qiu, Helena A. Yu, Travis J. Hollmann, Michael H. Roehrl, Christine A. Iacobuzio-Donahue, Joachim Silber, Sonali Sinha, Marina Asher, Irina Linkov, Umesh K. Bhanot, Jacklynn Egger, Sam E. Tischfield, Jordana Ray-Kirton, Jason C. Chang, Michael Offin, Andrew Chow, Metamia Ciampricotti, Joseph M. Chan, Helen H. Won, Mark T.A. Donoghue, Parvathy Manoj, Fathema Uddin, Fanli Meng, Shweta S. Chavan, Maysun M. Hasan, Yingqian A. Zhan, Hirokazu Taniguchi, Alvaro Quintanal-Villalonga
Supplemental tables S1-S15
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b59aeae9efc033bbf7f750d12903ac3
https://doi.org/10.1158/2159-8290.22540718
https://doi.org/10.1158/2159-8290.22540718
Autor:
Yingqian Zhan, Jason C. Chang, Irina Linkov, Shweta S Chavan, Travis J. Hollmann, Jordana Ray-Kirton, Joseph M. Chan, Metamia Ciampricotti, Triparna Sen, Sam E. Tischfield, J. Qiu, Maysun Hasan, Helena A. Yu, Joachim Silber, Richard Koche, Helen Won, Marina K. Baine, Brian Loomis, Umesh Bhanot, Charles M. Rudin, Natasha Rekhtman, Andrew Chow, Fathema Uddin, Jacklynn V. Egger, Álvaro Quintanal-Villalonga, Sonali Sinha, Fanli Meng, Michael H.A. Roehrl, Christine A. Iacobuzio-Donahue, P. Manoj, Michael Offin, John T. Poirier, Marina Asher, Elisa de Stanchina, Mark T.A. Donoghue, Hirokazu Taniguchi
Publikováno v:
Cancer Discovery. 11:3028-3047
Lineage plasticity is implicated in treatment resistance in multiple cancers. In lung adenocarcinomas (LUAD) amenable to targeted therapy, transformation to small cell lung cancer (SCLC) is a recognized resistance mechanism. Defining molecular mechan
Autor:
Jimmy L. Zhao, Michael J. Morris, Katia Manova Todorova, Tianhao Xu, Wouter R. Karthaus, Michael C. Haffner, Dana E. Rathkopf, Natasha Rekhtman, Ignas Masilionis, Afsar Barlas, Kristine M. Wadosky, Howard I. Scher, Dana Pe'er, Joachim Silber, Lawrence D. True, Peter S. Nelson, Joseph M. Chan, Ojasvi Chaudhary, Linas Mazutis, Kayla E. Lawrence, Charles L. Sawyers, Ronan Chaligne, David W. Goodrich, Achim A. Jungbluth, Philip A. Watson, Jungmin Choi, Martin P Roudier, Samir Zaidi, Irina Linkov, Anuradha Gopalan
Lineage plasticity is a well–established mechanism of resistance to targeted therapies in lung and prostate cancer, where tumors transition from adenocarcinoma to small–cell or neuroendocrine carcinoma. Through single–cell analysis of a cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c23edc86fc830f0ed4f2aa44578cb60
https://doi.org/10.1101/2021.11.01.466599
https://doi.org/10.1101/2021.11.01.466599
Autor:
Filemon S. Dela Cruz, Joseph G. McCarter, Daoqi You, Nancy Bouvier, Xinyi Wang, Kristina C. Guillan, Armaan H. Siddiquee, Katie B. Souto, Hongyan Li, Teng Gao, Dominik Glodzik, Daniel Diolaiti, Neerav N. Shukla, Joachim Silber, Umeshkumar K. Bhanot, Faruk Erdem Kombak, Diego F. Coutinho, Shanita Li, Juan E. Arango Ossa, Juan S. Medina-Martinez, Michael V. Ortiz, Emily K. Slotkin, Michael D. Kinnaman, Sameer F. Sait, Tara J. O'Donohue, Marissa Mattar, Maximiliano Meneses, Michael P. LaQuaglia, Todd E. Heaton, Justin T. Gerstle, Nicola Fabbri, Chelsey M. Burke, Irene M. Rodriquez-Sanchez, Christine A. Iacobuzio-Donahue, Julia L. Glade Bender, Ryan D. Roberts, Jason T. Yustein, Nino C. Rainusso, Brian D. Crompton, Elizabeth Stewart, Alejandro Sweet-Cordero, Leanne C. Sayles, Andrika D. Thomas, Michael H. Roehrl, Elisa de Stanchina, Elli Papaemmanuil, Andrew L. Kung
Publikováno v:
Cancer Research. 82:704-704
Background: Recapitulation of the full spectrum of genomic changes driving patient tumors have resulted in increased use of patient-derived xenograft (PDX) models in studies of basic cancer biology and preclinical drug development. Given the translat
Autor:
Alvaro Quintanal-Villalonga, Hirozaku Taniguchi, Yingqian A. Zhan, Maysun M. Hasan, Fanli Meng, Fathema Uddin, Mark Donoghue, Helen H. Won, Shweta S. Chavan, Joseph M. Chan, Metamia Ciampricotti, Andrew Chow, Michael Offin, Jason C. Chang, Jordana Ray-Kirton, Jacklynn Egger, Umesh K. Bhanot, Joachim Silber, Christine A. Iacobuzio-Donahue, Michael H. Roehrl, Travis J. Hollmann, Helena A. Yu, Natasha Rekhtman, John T. Poirier, Brian Houck-Loomis, Richard P. Koche, Charles M. Rudin, Triparna Sen
Lineage plasticity, a capacity to reprogram cell phenotypic identity under evolutionary pressure, is implicated in treatment resistance and metastasis in multiple cancers. In lung adenocarcinomas (LUADs) amenable to treatment with targeted inhibitors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30dd57d88e6590e3bdf0134326d08b02
https://doi.org/10.1101/2020.12.02.408476
https://doi.org/10.1101/2020.12.02.408476
Autor:
Sujatmi Hariono, Jason T. Huse, J. Graeme Hodgson, Rintaro Hashizume, Mitchel S. Berger, Scott R. VandenBerg, Joachim Silber, Nalin Gupta, Mamie Yu, C. David James, Tristan Felix
Publikováno v:
Silber, J; Hashizume, R; Felix, T; Hariono, S; Yu, M; Berger, MS; et al.(2013). Expression of miR-124 inhibits growth of medulloblastoma cells. Neuro-Oncology, 15(1), 83-90. doi: 10.1093/neuonc/nos281. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/9k7173fp
Neuro-oncology, vol 15, iss 1
Neuro-oncology, vol 15, iss 1
Medulloblastoma is the most common malignant brain tumor in children, and a substantial number of patients die as a result of tumor progression. Overexpression of CDK6 is present in approximately one-third of medulloblastomas and is an independent po
Whole exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma
Autor:
Joachim Silber, Daniel Gorovets, Timothy A. Chan, Edward R. Kastenhuber, Adriana Heguy, John H.J. Petrini, Akiko Inagaki, Jianan Zhang, Kasthuri Kannan, Jason T. Huse
Publikováno v:
Memorial Sloan Kettering Cancer Center
Oncotarget
Scopus-Elsevier
Oncotarget
Scopus-Elsevier
// Kasthuri Kannan 1,4 , Akiko Inagaki 2 , Joachim Silber 1,4 , Daniel Gorovets 1,4 , Jianan Zhang 1,4 , Edward R. Kastenhuber 1,4 , Adriana Heguy 4 , John H. Petrini 2 , Timothy A. Chan 3,4 , and Jason T. Huse 1,4 1 Department of Pathology, Memorial